Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G. Baumert(Kantonsspital Graubünden), Roger Stupp(Northwestern University), Mohamed Ben Hassel(University of Turin), Warren Mason(Princess Margaret Cancer Centre), Christian Hartmann(Medizinische Hochschule Hannover), Nicolas Dif(European Organisation for Research and Treatment of Cancer), Martin J. van den Bent(Erasmus MC Cancer Institute), Khê Hoang‐Xuan(Sorbonne Université), Johanna M. M. Gijtenbeek(Radboud University Nijmegen), Sebastian Kurscheid(Australian National University), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Jeremy Rees(National Hospital for Neurology and Neurosurgery), Jacoline E. C. Bromberg(Erasmus MC), Brian Thiessen(Princess Margaret Hospital), Jose Bravo-Marques(IPO Porto), Thierry Gorlia(European Organisation for Research and Treatment of Cancer), David Capper(German Cancer Research Center), Roelien H. Enting(University of Groningen), Monika E. Hegi(University Hospital of Lausanne), Andreas von Deimling(German Cancer Research Center), Christine Marosi, Carmen Balañá(Institut Català d'Oncologia), Robert Nordal, Johan M. Kros(Erasmus MC), Olivier Chinot(Aix-Marseille Université), Wolfgang Wick(German Cancer Research Center), Tzahala Tzuk-Shina(The University of Texas MD Anderson Cancer Center), Alba A. Brandes(Istituto delle Scienze Neurologiche di Bologna), F. Dhermain(Institut Gustave Roussy), L. Feuvret(Sorbonne Université), Denis Lacombe(European Organisation for Research and Treatment of Cancer), Gail Ryan(Peter MacCallum Cancer Centre), John P. Rossiter(Queen's University), Paul M. Clément(Universitair Ziekenhuis Leuven), Guy Kantor(Institut Bergonié), Michele Reni(San Raffaele University of Rome)
Cited by 504
Related Papers
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
|New England Journal of Medicine|2005|7.2k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k